10 years of tamoxifen better to prevent breast cancer, study finds

Women using tamoxifen to prevent a recurrence of breast cancer had better protection if they took the drug for 10 years instead of the standard five, Oxford University researchers reported in The Lancet. Breast cancer experts said the data, which showed a lower recurrence rate among women who took the drug longer, also may have implications for postmenopausal women who usually take other medications to prevent a recurrence.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC